US to Pay $2.1 Bln to Sanofi, GSK, in COVID-19 Vaccine Deal US to Pay $2.1 Bln to Sanofi, GSK, in COVID-19 Vaccine Deal

The U.S. government will pay $2.1 billion to Sanofi SA and GlaxoSmithKline Plc for COVID-19 vaccines to cover 50 million people and to underwrite the drugmakers ' testing and manufacturing.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news